Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin in Provoked Vestibulodynia
NCT02858219Phase 3Completed
- Sponsor
- CHU de Besançon
- Start
- May 2010
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in vestibulodynia, sponsored by CHU de Besançon. Started May 2010; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
vestibulodynia
Beyond the preview
Go deeper on NCT02858219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02858219.